Analysis of Treatment-Related Factors Affecting Mortality in Patients with Severe Necrotizing Acute Pancreatitis

Open access


The aim of the paper was to determine the factors related to the initial therapy that may contribute to death from severe necrotizing acute pancreatitis and to analyze their clinical importance as well as possible additive effects.

A retrospective case-control study included all adult patients treated for severe necrotizing acute pancreatitis in the Clinical Center of Kragujevac, Serbia, during the five-year period (2006-2010.). The cases (n = 41) were patients who died, while the controls (n = 69) were participants who survived. In order to estimate the relationship between potential risk factors and observed outcome, crude and adjusted odds ratios (OR) with 95 % confidence intervals (CI) were calculated in logistic regression models.

Significant association with observed outcome was shown for the use of gelatin and/or hydroxyethyl starch (adjusted OR 12.555; 95 % CI 1.150-137.005), use of albumin (adjusted OR 27.973; 95 % CI 1.741-449.373), use of octreotide (adjusted OR 16.069; 95 % CI 1.072-240.821) and avoiding of enteral feeding (adjusted OR 3.933; 95 % CI 1.118-13.829), while the use of nonsteroidal anti-inflammatory drugs had protective role (adjusted OR 0.057; 95 % CI 0.004-0.805).

The risk of death in patients with predicted severe necrotizing acute pancreatitis could be reduced with avoidance of treatment with colloid solutions, albumin and octreotide, as well as with an early introduction of oral/enteral nutrition and use of nonsteroidal anti-inflammatory drugs.

1. Tenner S, Baillie J, Dewitt J, et al. American College of Gastroenterology. American college of gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol 2013; 108: 1400-15.

2. Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis 2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013; 62: 102-11.

3. Petrov MS, Shanbhag S, Chakraborty M, et al. Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis. Gastroenterology 2010; 139: 813-20.

4. Doctor N, Agarwal P, Gandhi V. Management of severe acute pancreatitis. Indian J Surg 2012; 74: 40-6.

5. Bradley EL III. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11 through 13, 1992. Arch Surg 1993; 128: 586-90.

6. Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: a reliable descriptor of complex clinical outcome.Crit Care Med 1995; 23: 1638-52.

7. Schütte K, Malfertheiner P. Markers for predicting severity and progression of acute pancreatitis. Best Pract Res ClinGastroenterol 2008; 22: 75-90.

8. Andersson B, Appelgren B, Sjödin V, et al. Acute pancreatitis - costs for healthcare and loss of production. Scand JGastroenterol 2013; 48: 1459-65.

9. Parsi MA. NSAIDs for prevention of pancreatitis after endoscopic retrograde cholangiopancreato graphy: ready for prime time? World J Gastroenterol 2012; 18: 3936-7.

10. Khoshbaten M, Khorram H, Madad L, et al. Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis. J GastroenterolHepatol 2008; 23: 11-6.

11. Sotoudehmanesh R, Khatibian M, Kolahdoozan S, et al. Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP. Am J Gastroenterol 2007; 102: 978-83.

12. Chan YC, Leung PS. Acute pancreatitis: animal models and recent advances in basic research. Pancreas 2007; 34: 1-14.

13. De Almeida JL, Jukemura J, Coelho AM, et al. Inhibition of cyclooxygenase-2 in experimental severe acute pancreatitis. Clinics (Sao Paulo) 2006; 61: 301-6.

14. Dai HF, Wang XW, Zhao K. Role of nonsteroidal anti-inflammatory drugs in the prevention of post-ERCP pancreatitis: a meta-analysis. HepatobiliaryPancreat Dis Int 2009; 8: 11-6.

15. Aufenanger J, Samman M, Quintel M, et al. Pancreatic phospholipase A2 activity in acute pancreatitis: a prognostic marker for early identification of patients at risk. ClinChem Lab Med 2002; 40: 293-7.

16. Mäkelä A, Kuusi T, Schröder T. Inhibition of serum phospholipase-A2 in acute pancreatitis by pharmacological agents in vitro. Scand J Clin Lab Invest 1997; 57: 401-7.

17. Nevalainen TJ. The role of phospholipase A2 in acute pancreatitis. Z Med Lab Diagn 1989; 30: 299-303.

18. Pezzilli R , U omo G , G abbrielli A , e t a l. A prospective multicentre survey on the treatment of acute pancreatitis in Italy. Dig Liver Dis 2007; 39: 838-46.

19. BasurtoOna X, Rigau Comas D, Urrútia G. Opioids for acute pancreatitis pain. Cochrane Database Syst Rev 2013; 7: CD009179.

20. Marshall JC. The Multiple Organ Dysfunction (MOD) Score. Sepsis 1997; 1: 49-52.

21. Johnson CD, Abu-Hilal M. Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis. Gut 2004; 53: 1340-4.

22. Petrov MS, Zagainov VE. Influence of enteral versus parenteral nutrition on blood glucose control in acute pancreatitis: a systematic review. ClinNutr 2007; 26: 514-23.

23. Wang G, Wen J, Xu L, et al. Effect of enteral nutrition and ecoimmunonutrition on bacterial translocation and cytokine production in patients with severe acute pancreatitis. J Surg Res 2013; 183: 592-7.

24. Marik P, Raghavan M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. IntCare Med 2004; 30: 748-56.

25. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo ClinProc 2003; 78: 1471-8.

26. Tang WF, Wang YG, Zhu L, et al. Effect of somatostatin on immune inflammatory response in patients with severe acute pancreatitis. J Dig Dis 2007; 8: 96-102.

27. Wang G , W en J , W ilbur R R, W en P , Z hou S F, Xiao X. The Effect of Somatostatin, Ulinastatin and Salvia miltiorrhiza on Severe Acute Pancreatitis Treatment. Am J Med Sci 2013; 346: 371-6.

28. Uhl W, Büchler MW, Malfertheiner P, et al. A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis. Gut 1999; 45: 97-104.

29. Cavallini G, Frulloni L. Somatostatin and octreotide in acute pancreatitis: the never-ending story. Dig Liver Dis 2001; 33: 192-201.

30. Wall I, Badalov N, Baradarian R, et al. Decreased mortality in acute pancreatitis related to early aggressive hydration. Pancreas 2011; 40: 547-50.

31. De-Madaria E, Soler-Sala G, Sánchez-Payá J, et al. Influence of fluid therapy on the prognosis of acute pancreatitis: a prospective cohort study. Am J Gastroenterol 2011; 106: 1843-50.

32. Trikudanathan G, Navaneethan U, Vege SS. Current controversies in fluid resuscitation in acute pancreatitis: a systematic review. Pancreas 2012; 41: 827-34.

33. Zhao G, Zhang J G, W u HS, e t a l. E ffects o f different resuscitation fluid on severe acute pancreatitis. World JGastroenterol 2013; 19: 2044-52.

34. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367: 1901-11.

35. Gardner TB, Vege SS, Chari ST, et al. Faster rate of initial fluid resuscitation in severe acute pancreatitis diminishes in-hospital mortality. Pancreatology 2009; 9: 770-6.

36. De-Madaria E. Latest advances in acute pancreatitis. GastroenterolHepatol 2012; 35(suppl 1):98-101.

37. Caraceni P, Domenicali M, Tovoli A, et al. Clinical indications for the albumin use: Still a controversial issue. Eur J Intern Med 2013; 24: 721-8.

38. Chen Y, Zhang ZW, Wang B, et al. Relationship between early serum albumin variation and prognosis in patients with severe acute pancreatitis treated in ICU. Sichuan Da XueXueBao Yi Xue Ban 2013; 44: 237-41.

39. Xue P, Huang ZW, Li YH, et al. Clinical study on severe acute pancreatitis associated with hypoalbuminemia in early stage. Zhong Xi Yi Jie He XueBao 2005; 3: 443-5.

Acta Facultatis Medicae Naissensis

The Journal of Faculty of Medicine in Nis

Journal Information

Cite Score 2018: 0.33

SCImago Journal Rank (SJR) 2018: 0.134
Source Normalized Impact per Paper (SNIP) 2018: 0.287


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 210 123 10
PDF Downloads 97 77 2